John Bernard Payne, President and CEO at Zivo Bioscience, Inc. (ZIVO), bought 6,343 shares at $15.76 ($100K) on 2024-10-16, disclosed to the SEC on 2024-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ZIVO | BUY | 2022-01-28 | $23K | — | Filing → |